Moreover, we discussed the efficacy of immunotherapy in driven gene mutations in lung cancer, including KRAS, TP53, EGFR, ALK, ROS1, KEAP1, ZFHX3, PTCH1, and STK11. Here, PTCH1 is linked to lung carcinoma.